Background The angiotensin receptor–neprilysin inhibitor sacubitril–valsartan led to a
reduced risk of hospitalization for heart failure or death from cardiovascular causes among …

Importance Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes
coronavirus disease 2019 (COVID-19) has reached a pandemic level. Coronaviruses are …

Quantification of cardiac chamber size, ventricular mass, and function ranks among the
most clinically important and most frequently requested tasks of echocardiography. …

RAAS Inhibitors in Patients with Covid-19 The effects of renin–angiotensin–aldosterone system
blockers on angiotensin-converting enzyme 2 levels and activity in humans are uncertain…

Background In patients with type 2 diabetes, inhibitors of sodium–glucose cotransporter 2 (SGLT2)
reduce the risk of a first hospitalization for heart failure, possibly through glucose-…

… Dr Solomon has received consulting fees from Novartis and Bayer and research grants from
the National Heart, Lung, and Blood Institute. Dr Sweitzer has received research grants from …

Background Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization
for heart failure and cardiovascular death among patients with chronic heart failure …

Background We compared the angiotensin receptor–neprilysin inhibitor LCZ696 with
enalapril in patients who had heart failure with a reduced ejection fraction. In previous studies, …

Objectives: Upon completing the reading of this article, the participants will better be able to:
1. Describe the conventional two-dimensional acoustic windows required for optimal …

Background This trial was designed to determine whether cardiac-resynchronization therapy
(CRT) with biventricular pacing would reduce the risk of death or heart-failure events in …